Surface Electromyography in the Detection and Assessment of Bruxism

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-40
SponsorEscoles Universitaries Gimbernat

About this trial

Introduction:

Sleep bruxism is defined as the repetitive activity of the masticatory muscles, characterized by clenching or grinding of the teeth. Studies confirm the association between sleep bruxism and episodes of masticatory muscle activity, with an increase in autonomic sympathetic activity observed during transient periods of sleep. This is associated with nocturnal awakenings, related to increased cardiac, cerebral (cortical arousal), respiratory, and muscular activity.

Objectives: The main objectives are "To study the mean power frequency (MPF) of the masticatory muscles measured by surface electromyography (sEMG) in the general population (with and without bruxism according to ICSD-3 and DC/TMD criteria)"; and "to assess the effectiveness of manual therapy applied to structures adjacent to the vagus nerve based on its impact on orofacial pain and symptomatology in patients with bruxism".

Material and Methods:

A cross-sectional observational study and a randomized controlled experimental study were designed. The first will analyze data collected by sEMG in the masticatory muscles, at rest and during maximum clenching, comparing results between bruxists and non-bruxists. The second will analyze, compared to the control group, data collected on signs (range of motion alteration, presence of sounds), symptomatology (pain, headaches, sensation of blockage, functional limitation) caused by bruxism, sleep quality (Pittsburgh Sleep Quality Index (PSQI)), oral health-related quality of life (OHIP-14), stress and anxiety status (Perceived Stress Scale and GAD-7 (Generalized Anxiety Disorder-7), respectively), and sympathetic-vagal balance (Heart Rate Variability in its frequency and time domains) before and after a manual therapy intervention on structures adjacent to the vagus nerve pathway (head, neck, thorax, diaphragm, abdomen). The collected data will be analyzed using IBM SPSS® version 25.0.0.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Abnormal tooth wear consistent with reports of clenching/grinding the teeth during sleep

Transient morning pain or fatigue in the jaw muscles; and/or temporal headaches; and/or jaw locking upon awakening, consistent with reports of clenching/grinding the teeth during sleep

Interview: During the interview, subjects are asked about the following symptoms: reports of regular or frequent tooth grinding during sleep, muscle fatigue, temporal headache, transient morning muscle pain in the jaw, and jaw locking upon awakening.

Physical examination: Presence or signs suggesting abnormal dental wear, such as teeth with flattened cusps and/or loss of contour with dentin exposure.

Disqualifiers

Having suffered direct trauma, mandibular fractures, or surgeries in the orofacial region.

Loss of more than 2 teeth, except for the third molar.

Use of muscle relaxant medication or medications that may influence motor behavior.

Having received botulinum toxin treatment in the last 6 months.

Trial population

The observational study will include two groups of patients: the first, with active symptoms compatible with nocturnal bruxism, and the second, asymptomatic patients without signs of bruxism or other craniofacial pathologies. To this end, 54 participants aged between 18 and 40 years will be recruited.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • sEMG

    Diagnostic test

    The spectral characteristics in the amplitude domain will be recorded through the root mean square (RMS, unit: μV) or the mean power frequency (MPF, unit: Hz) of the musculature to be evaluated by means of EMGs, with the electrodes placed parallel to the muscle fibers of the temporal, masseter, and suprahyoid muscles. Standardized EMGs will be recorded and compared in resting position and during maximum voluntary clenching

Treatment groups

54 Participants
are divided into 2 treatment groups
Group A: Group 1 (Bruxism)1 intervention
Group B: Group 2 (No bruxism)1 intervention

Trial outcomes

Primary outcomes

1

Motor recruitment pattern of the masseter, temporalis, and suprahyoid muscles

In resting position and during maximum clenching, as measured by the mean power frequency (MPF) recorded in a surface electromyography.

Time frame
1 day, baseline

Secondary outcomes

1

Orofacial Pain (1)

Assessment tests for TMD and bruxism condition "AXIS- I" is the assessment tool with a "Symptom questionnaire"

Time frame
1 day, baseline
2

Orofacial Pain (2)

Assessment tests for TMD and bruxism condition "AXIS- I" is the assessment tool with a Pressure Pain Threshold of masseter and temporalis muscles with a DC/ TMD EXAMINATION FORM.

Time frame
1 day, baseline
3

Orofacial Pain (3)

Assessment tests for TMD and bruxism condition "AXIS -II" throught the "Graded chronic pain scale version 2.0"

Time frame
1 day, baseline
4

Range of Motion (1)

Assessment tests for TMD and bruxism condition "AXIS- I" is the assessment tool with a "Symptom questionnaire".

Time frame
1 day, baseline

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Escoles Universitaries Gimbernat

Lead sponsor

Universitat Internacional de Catalunya

Collaborator

This trial is not recruiting at the moment. You can still explore other options: